Canada: Mouse Trapped: Canada’s Supreme Court Corners Harvard Mouse in Schmeiser v. Monsanto

Last Updated: November 16 2004

Published in International Asset Management, Oct./Nov. 2004.

For the second time in two years, the Supreme Court of Canada has split on the question of the scope of patent protection for higher life forms. In the most recent case—Schmeiser v. Monsanto—the Supreme Court ruled 5:4 that Schmeiser infringed Monsanto’s patent to modified canola genes and cells by planting seeds and growing plants containing the patented genes and cells, although Monsanto’s patent did not claim canola plants or seeds themselves.

The decision is welcome news for the biotechnology and agriculture sectors in Canada, which were concerned that the Court might apply its controversial 2002 judgment in Harvard College v. Canada (Commissioner of Patents) (Harvard Mouse). In that case, a different 5:4 majority of the Court decided that higher life forms, including plants and animals, are unpatentable. That decision seems to have been effectively overruled by Schmeiser. The Schmeiser decision is also important for patent applicants in Canada because claims to modified genes and cells—of plants or animals—should now be allowable without the post–Harvard Mouse limitations imposed by the Canadian Intellectual Property Office (CIPO).


Percy Schmeiser, a Saskatchewan farmer, was sued by Monsanto for patent infringement. The patent in question claimed genetically engineered genes, and cells containing those genes, that confer herbicide resistance on canola plants. The patent did not claim the canola plants or seeds themselves. Monsanto alleged that Schmeiser had infringed its patent rights by reproducing canola seeds and plants that contained genes and cells covered by Monsanto’s patent claims, and by selling the harvested canola seed.

Three principal issues were argued before the Supreme Court: (1) Was the scope of Monsanto’s patent sufficient to permit Monsanto to claim rights in canola plants and seeds carrying the patented genes and cells? (2) If so, what constitutes infringing "use" of Monsanto’s invention? and (3) How should the law deal with "innocent bystanders" whose personal property inadvertently becomes contaminated with patented material? The Supreme Court was also asked to consider Monsanto’s remedy if Schmeiser was found to have infringed.

The majority decision

Five judges decided that Schmeiser had infringed Monsanto’s patent. In so finding, the majority decision makes important rulings on the scope of patent claims to genes and cells, and on the meaning of infringing "use" of an invention.

Gene and cells claims give rise to enforcement rights over canola plants

The majority rejected Schmeiser’s argument that, on the reasoning in Harvard Mouse, the modified gene and cell claims of Monsanto’s patent are unpatentable subject matter. The majority observed that there had been no disagreement in that case that genes and cells are patentable. On this basis, it held that Monsanto’s patent is valid. Significantly, the majority held that the question whether patent protection for genes and cells extends to activities involving the whole plant is irrelevant to a validity analysis; it is relevant only to infringement. It follows that gene and cell claims can confer enforcement rights over whole plants despite the unpatentability of the plants themselves.

Rebuttable presumption of infringing use

A second key ruling concerns whether possession can amount to infringing "use" of an invention.

In this case, the evidence was that Schmeiser collected, saved and planted seed containing Monsanto’s patented genes and cells. However, Schmeiser contended that he did not "use" Monsanto’s invention because the real benefit of the modified genes and cells was to confer herbicide resistance on the canola plants. A farmer could kill weeds by spraying with Monsanto’s herbicide rather than by tillage, and so reduce labor costs. Schmeiser had not sprayed his crops with Monsanto’s herbicide.

The majority rejected this argument, holding that possession, at least in a commercial context, raises a presumption of use. While intention is usually not relevant to an infringement analysis, the majority held that the presumption can be rebutted by establishing the absence of an intention to employ or gain any advantage from the invention. Schmeiser had failed to adduce sufficient evidence to rebut the presumption in this case. For the majority, it was not enough to refrain from spraying with herbicide because the patented genes and cells had a "stand-by utility"—that is, their presence in the canola plants made it possible to spray with herbicide if needed, even if spraying had not in fact been done.

Innocent bystanders

The majority rejected Schmeiser’s contention that an "innocent bystander" should be granted an implied licence to use an invention that becomes intermixed with personal property. Rather, an innocent bystander could refute the presumption of infringing use by showing, for instance, that he or she had acted quickly to have the patented material removed.


The majority held that there was no evidence that Schmeiser had earned any profit from Monsanto’s invention. He had not sprayed the crop with herbicide and so had not reduced his production costs. Accordingly, there was no evidence of a causal connection between the profits that Schmeiser was found to have earned by growing the patented canola and the invention. The majority thus held that Monsanto was entitled to nothing on its claim for an accounting of profits.

The majority’s ruling signifies that caution is in order when electing a remedy for infringement. Where there is a question whether the utility of the invention has been exploited, it may be difficult to prove the required causal connection between any profits earned by the defendant and the invention itself. The decision also underlines the importance in such cases of a complete evidentiary record.


Claims to plant and animal genes and cells in vivo are allowable

Applicants for patents in Canada will welcome Schmeiser’s case. Since the Supreme Court’s decision in Harvard Mouse, CIPO had initially refused to grant claims to genes and cells except where "isolated," presumably on the theory that unlimited gene and cell claims could indirectly confer patent rights over plants. The judgment in Schmeiser means that gene and cell claims—whether for plants or animals—should be allowable without being limited to isolated material. CIPO’s policy on gene and cell claims now appears to reflect this, at least with respect to plants.

Indirect rights to whole plants and animals are available

Monsanto’s claims to genes and plant cells were held by the majority to confer enforcement rights over the entire plant. This outcome is strikingly at odds with the Court’s decision in Harvard Mouse, and in fact seems effectively to overrule it.

On the reasoning in Schmeiser, claims to genes and animal cells in vivo should confer enforcement rights over animals themselves. The Schmeiser decision may stimulate innovation in the drug development sector because patentees of transgenic animals genes and cells may now have an effective means of enforcing their patent rights against infringers, regardless of the unpatentability of the whole animal. While it may take another Supreme Court decision to confirm this, the state of the law at present is encouraging for inventors and investors in biotechnology in Canada.

Cynthia Tape is a lawyer in the Toronto office of Torys LLP. Cynthia practises intellectual property law in the areas of biotechnology, pharmaceuticals, and food and drug regulatory law.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.